HOME >> BIOLOGY >> NEWS
Anti cancer virotherapy well tolerated in first human administration, research finds

(Banff, Canada March 14, 2005) An international medical conference here heard that an Australian developed anti-cancer therapy based on the use of a common cold virus to control cancer cell growth has begun safety testing in human subjects.

The research was presented to the third International Meeting on Replicating Oncolytic Virus Therapeutics, on Friday 11 March by Newcastle University associate professor, Darren Shafren.

The technology is licensed to Australian Stock Exchange listed biotechnology company, Psiron Limited (ASX:PSX).

Professor Shafren has previously tested this virotherapy on cancer tumours in mice and this is the first testing in humans. Two patients only were approved to receive this virotherapy.

Professor Shafren reported to the conference that this research team had injected a single dose of Coxsackie A21 (CVA21) virus directly into the advanced melanoma tumours of these patients with end stage disease.

Both patients had many sites of spread melanoma tumours and injected and non-injected tumours were subsequently removed from the patients.

Professor Shafren's group observed no "systemic toxic effects or localised inflammation" as a result of the injections of the viral material and basic blood chemistry and liver enzyme levels remain unchanged in the these two patients.

Professor Shafren told conference delegates that these findings suggested that administration of a single dose of CVA21 directly into a cancerous tumour was well tolerated.

"Administration of CVA21 may be of potential therapeutic benefit in controlling the spread of melanoma," Professor Shafren said.

CVA21 is one of a small group of naturally occurring rather than genetically modified viruses the Shafren team has been investigating as potential therapies for different hard to treat malignancies including melanoma and ovarian cancer.

These viruses occur naturally and routinely in the community causing m
'"/>

Contact: David Sheon
dsheon@sciwords.com
202 518 6321
SciWords
14-Mar-2005


Page: 1 2

Related biology news :

1. Protein chatter linked to cancer activation
2. Newly created cancer stem cells could aid breast cancer research
3. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
4. ESF EURYI award winner aims to stop cancer cells reading their own DNA
5. No evidence that widely prescribed statins protect against prostate cancer
6. A study by the MUHC and McGill University opens a new door to understanding cancer
7. New study suggests Concord grape juice may provide protection against breast cancer
8. New test improves detection of liver cancer
9. High-intensity ultrasound may launch attack on cancer, wherever it lurks
10. Unknotting DNA clue to cancer syndrome
11. Biologists at Tufts University discover 1 reason why chromosomes break, often leading to cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2019)... ... May 20, 2019 , ... Dr. David Greene , ... The documentary, Stem Cell Therapy: Biotechnology to the Rescue, was produced by Award Winning ... Greene was interviewed in regards to the safety of the procedures along with the ...
(Date:5/21/2019)... Pa. (PRWEB) , ... May 20, 2019 , ... ... for the health care field, today announced a 96.15% pass rate for first-time ... of 2019. This surpasses the national average of 76.43% by nearly 20 points. ...
(Date:5/16/2019)... (PRWEB) , ... May 16, 2019 , ... In a ... and Technology in Rockville, Maryland, March 18-19 of this year, Asymmetrex founder ... the feasibility of standards for counting therapeutic adult tissue stem cells. Many of ...
Breaking Biology News(10 mins):
(Date:4/18/2019)... ... April 18, 2019 , ... Taking a ... includes a chemical engineer at Worcester Polytechnic Institute (WPI) has developed a novel ... possible to manufacture isobutanol and other biofuels more economically. , Isobutanol, like ethanol, ...
(Date:4/16/2019)... ANTONIO (PRWEB) , ... April 16, 2019 , ... ... human identification systems, applications, and technology, today announced that Bank South Pacific (BSP), ... a competitive RFP process. The bank awarded Fulcrum a contract to deliver a ...
(Date:4/12/2019)... (PRWEB) , ... April 12, 2019 , ... ... recent developments in neurotechnology and will educate about innovative tools and devices being ... your local listings for more information. , This segment of Advancements will focus ...
(Date:4/10/2019)... ... ... After more than three months of renovation, Lajollacooks4u is set to reveal its ... modern lighting and fixtures, and will provide additional workspace for the many guests who ... the demand for our team-building events and cooking classes over the last eleven years,” ...
Breaking Biology Technology:
Cached News: